Given that the E169A substitution mutation has been described in two patients diagnosed with chronic mucocutaneous candidiasis, it is evident that the proposed auto-inhibitory mechanism of STAT1 inactivation has great clinical significance. This evidence concerns the gene STAT1 and chronic mucocutaneous candidiasis.